Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Bausch Health Companies Inc (BHC)

Bausch Health Companies Inc (BHC)
4.55 x 1 4.99 x 1
Post-market by (Cboe BZX)
4.72 -0.38 (-7.45%) 04/21/25 [NYSE]
4.55 x 1 4.99 x 1
Post-market 4.72 unch (unch) 16:20 ET
Quote Overview for Mon, Apr 21st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
4.59
Day High
5.11
Open 5.08
Previous Close 5.10 5.10
Volume 3,076,400 3,076,400
Avg Vol 3,056,310 3,056,310
Stochastic %K 31.94% 31.94%
Weighted Alpha -54.12 -54.12
5-Day Change +0.40 (+9.26%) +0.40 (+9.26%)
52-Week Range 3.96 - 9.85 3.96 - 9.85
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,876,463
  • Shares Outstanding, K 367,934
  • Annual Sales, $ 9,625 M
  • Annual Income, $ -46,000 K
  • EBIT $ 2,652 M
  • EBITDA $ 4,056 M
  • 60-Month Beta 0.43
  • Price/Sales 0.17
  • Price/Cash Flow 0.58
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 110.37% ( +26.95%)
  • Historical Volatility 74.14%
  • IV Percentile 95%
  • IV Rank 52.14%
  • IV High 177.43% on 07/24/24
  • IV Low 37.30% on 05/24/24
  • Put/Call Vol Ratio 0.91
  • Today's Volume 2,493
  • Volume Avg (30-Day) 4,551
  • Put/Call OI Ratio 3.00
  • Today's Open Interest 166,838
  • Open Int (30-Day) 188,382

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 1.46
  • Number of Estimates 5
  • High Estimate 3.76
  • Low Estimate 0.78
  • Prior Year 0.59
  • Growth Rate Est. (year over year) +147.46%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.25 +11.06%
on 04/11/25
Period Open: 7.16
7.45 -36.64%
on 03/25/25
-2.44 (-34.08%)
since 03/21/25
3-Month
4.25 +11.06%
on 04/11/25
Period Open: 7.47
8.02 -41.15%
on 01/24/25
-2.75 (-36.81%)
since 01/21/25
52-Week
3.96 +19.19%
on 07/24/24
Period Open: 8.69
9.85 -52.08%
on 11/04/24
-3.97 (-45.68%)
since 04/19/24

Most Recent Stories

More News
U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and Against Norwich

LAVAL, QC / ACCESS Newswire / April 17, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health"), and its gastroenterology business Salix Pharmaceuticals, Inc., today...

BHC.TO : 6.51 (-7.92%)
BHC : 4.72 (-7.45%)
Bausch Health Announces Adoption of Shareholder Rights Plan

LAVAL, QC / ACCESS Newswire / April 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health") announces today that its board of directors (the "Board") has approved...

BHC.TO : 6.51 (-7.92%)
BHC : 4.72 (-7.45%)
Bausch Health Announces Ortho Dermatologics 2025 ASPIRE HIGHER Scholarship Program

Bausch Health is offering scholarships to six students impacted by dermatologic conditions, with application submissions open through June 11, 2025

BHC.TO : 6.51 (-7.92%)
BHC : 4.72 (-7.45%)
Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance Sign Letter of Intent for Public Drug Plan Coverage of (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris

LAVAL, QC / ACCESS Newswire / April 9, 2025 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that it has signed a letter of intent with the pan-Canadian...

BHC.TO : 6.51 (-7.92%)
BHC : 4.72 (-7.45%)
Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month

Bausch Health's gastroenterology business, Salix Pharmaceuticals, recognizes the complexities of irritable bowel syndrome (IBS) and seeks to make a difference in how the condition is perceived, diagnosed...

BHC.TO : 6.51 (-7.92%)
BHC : 4.72 (-7.45%)
Bausch Health to Announce First Quarter Results on April 30

LAVAL, QC / ACCESS Newswire / March 27, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release first quarter financial results after market close on Wednesday, April 30, 2025. Bausch Health...

BHC.TO : 6.51 (-7.92%)
BHC : 4.72 (-7.45%)
Bausch Health Announces Pricing of Upsized Private Offering of Senior Secured Notes

LAVAL, QC / ACCESS Newswire / March 25, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health") today announced that it has priced its previously announced offering (the...

BHC.TO : 6.51 (-7.92%)
BHC : 4.72 (-7.45%)
Bausch Health Announces Conditional Redemption of Senior Notes

LAVAL, QC / ACCESS Newswire / March 21, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health") today announced that (i) it has delivered conditional notices of redemption...

BHC.TO : 6.51 (-7.92%)
BHC : 4.72 (-7.45%)
Bausch Health Announces Launch of Private Offering of Senior Secured Notes and Conditional Redemption of Senior Notes

LAVAL, QC / ACCESS Newswire / March 19, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health") today announced that it has launched an offering (the "Offering") of $4.0...

BHC.TO : 6.51 (-7.92%)
BHC : 4.72 (-7.45%)
Bausch Health Announces Launch of Syndication of New Senior Secured Credit Facilities

Transaction is part of a broader refinancing initiative aimed at opportunistically accessing capital markets to address near- and mid-term maturities

BHC.TO : 6.51 (-7.92%)
BHC : 4.72 (-7.45%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic...

See More

Key Turning Points

3rd Resistance Point 5.54
2nd Resistance Point 5.33
1st Resistance Point 5.02
Last Price 4.72
1st Support Level 4.50
2nd Support Level 4.29
3rd Support Level 3.98

See More

52-Week High 9.85
Fibonacci 61.8% 7.60
Fibonacci 50% 6.91
Fibonacci 38.2% 6.21
Last Price 4.72
52-Week Low 3.96

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro